Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Cancer. 2010 Jan;10(1):51-7. doi: 10.1038/nrc2772.

Senescence in tumours: evidence from mice and humans.

Author information

1
Spanish National Cancer Research Centre, Madrid, Spain. mcollado@cnio.es

Abstract

The importance of cellular senescence, which is a stress response that stably blocks proliferation, is increasingly being recognized. Senescence is prevalent in pre-malignant tumours, and progression to malignancy requires evading senescence. Malignant tumours, however, may still undergo senescence owing to interventions that restore tumour suppressor function or inactivate oncogenes. Senescent tumour cells can be cleared by immune cells, which may result in efficient tumour regression. Standard chemotherapy also has the potential to induce senescence, which may partly underlie its therapeutic activity. Although these concepts are well supported in mouse models, translating them to clinical oncology remains a challenge.

PMID:
20029423
PMCID:
PMC3672965
DOI:
10.1038/nrc2772
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center